L‐Cysteine and N‐Acetylcysteine Supplementation Improves Clinical Outcome in a Patient With COXPD10
ABSTRACT MTO1 is a nuclear gene that encodes a mitochondrial protein essential for modifying mitochondrial transfer RNAs (tRNAs) and stabilizing codon‐anticodon interactions to ensure accurate and efficient mitochondrial protein synthesis and oxidative phosphorylation.
Nishitha R. Pillai +5 more
wiley +1 more source
Guillain-Barre Syndrome With Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]
Hsu CM, Lin PH, Chiu CH, Hsiao HH.
europepmc +1 more source
Microbiota injury during conditioning for allogeneic hematopoietic stem cell transplantation. [PDF]
Lipan LE +7 more
europepmc +1 more source
Drug-Free Remission of VEXAS Syndrome Without Stem Cell Transplantation. [PDF]
Warren J, Smylie C, Milne A.
europepmc +1 more source
The feasibility of ovarian tissue cryopreservation in selected females after hematopoietic stem cell transplantation. [PDF]
Cheng J +15 more
europepmc +1 more source
Stem cell transplantation in head and neck oncology: Integrating oncologic treatment and maxillofacial reconstruction. [PDF]
Zeppieri M +8 more
europepmc +1 more source
Treosulfan-Based Conditioning in Allogeneic Stem Cell Transplantation for Myelofibrosis: A Systematic Review. [PDF]
Nasiri A +3 more
europepmc +1 more source
Related searches:
Stem cell transplantation in pediatric patients with leukemia has been a matter of debate since the first successful transplantation in a child with aplastic anemia in Germany in 1975. Since then, there has been a long way to implement fully stem cell transplantation strategies into the treatment studies organized within BFM Groups for first line or ...
D, Niethammer +3 more
openaire +2 more sources
Allogeneic Stem Cell Transplantation
Transplantation Proceedings, 2005Allogeneic stem cell transplantation (HSCT) requires the harvest of an adequate number of stem cells (SC) from a histocompatible donor and their infusion into a patient following a conditioning regimen. During the past 35 years, the role of HSCT has changed from an experimental procedure for terminally ill patients to a curative treatment.
BOSI, ALBERTO, BARTOLOZZI B, GUIDI S.
openaire +3 more sources

